Barinthus Biotherapeutics plc. (BRNS) insider trading
Every open-market stock purchase and sale by Barinthus Biotherapeutics plc. executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.74 on Sep 8, 2026.
Recent BRNS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | Oxford Science Enterprises plc (Insider) | Sold (not open market) | $977K |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Joseph Scheeren (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Robin Wright (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Anne M. Phillips (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Pierre A. Morgon (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Pierre A. Morgon (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Pierre A. Morgon (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Pierre A. Morgon (Director) | Sold (not open market) | — |
| Sep 9, 2026 | Pierre A. Morgon (Director) | Sold (not open market) | — |
Who's trading BRNS
- Robin Wright, Director: other filings, last Sep 9, 2026
- Karen A Dawes, Director: other filings, last Sep 9, 2026
- William Enright, CEO: other filings, last Sep 9, 2026
- Oxford Science Enterprises plc, Insider: other filings, last Sep 9, 2026
- Anne M. Phillips, Director: other filings, last Sep 9, 2026
- Joseph Scheeren, Director: other filings, last Sep 9, 2026
- Alex Hammacher, Director: other filings, last Sep 9, 2026
- Leon Hooftman, C-suite exec: other filings, last Sep 9, 2026
- Pierre A. Morgon, Director: other filings, last Sep 9, 2026
Get free alerts when an insider at Barinthus Biotherapeutics plc. files a new trade →